People · Operator

Christopher R. Johnson

Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology

1
Companies
1
Filings
$8.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Sun BioPharma, Inc.BiotechnologySeed$8.0M$52.2M2014
Operator network

Christopher R. Johnson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

DAVID B. KAYSEN · 4 companies · 1 sharedDAVID B. KAYSENThomas X. Neenan · 3 companies · 1 sharedThomas X. NeenanD. Robert Schemel · 2 companies · 1 sharedD. Robert SchemelJeffrey R. Harder · 2 companies · 1 sharedJeffrey R. HarderMichael T. Cullen · 2 companies · 1 sharedMichael T. CullenPAUL W. SCHAFFER · 2 companies · 1 sharedPAUL W. SCHAFFERClifford F. McCurdy, III · 1 companies · 1 sharedClifford F. McCur…Daniel E. Ryweck · 1 companies · 1 sharedDaniel E. RyweckDonald R. Schemel · 1 companies · 1 sharedDonald R. SchemelDouglas M. Polinsky · 1 companies · 1 sharedDouglas M. Polins…Paul M. Herron · 1 companies · 1 sharedPaul M. HerronRandall L. Johnson · 1 companies · 1 sharedRandall L. JohnsonRyan R. Gilbertson · 1 companies · 1 sharedRyan R. GilbertsonSuzanne X. Gagnon · 1 companies · 1 sharedSuzanne X. GagnonSun BioPharma, Inc. · $8.0M raisedSun BioPharma, Inc.Christopher R. JohnsonCJ
Christopher R. Johnson Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Christopher R. Johnson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
DAVID B. KAYSEN14
Thomas X. Neenan13
D. Robert Schemel12
Michael T. Cullen12
Jeffrey R. Harder12
PAUL W. SCHAFFER12
Ryan R. Gilbertson11
Clifford F. McCurdy, III11
Suzanne X. Gagnon11
Donald R. Schemel11
Daniel E. Ryweck11
Randall L. Johnson11
Douglas M. Polinsky11
Paul M. Herron11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.